Literature DB >> 15629758

Ubiquitin-proteasome system and Parkinson's diseases.

Ranjita Betarbet1, Todd B Sherer, J Timothy Greenamyre.   

Abstract

Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by nigrostriatal dopaminergic degeneration and development of cytoplasmic inclusions known as Lewy bodies. To date, the mechanisms involved in PD pathogenesis are not clearly understood. Clues from genetic studies including identification of mutations in genes for alpha-synuclein, parkin, and ubiquitin carboxy hydrolase L1 associated with familial PD and the presence of proteinaceous cytoplasmic inclusions in spared dopaminergic nigral neurons in sporadic cases of PD have suggested an important role for ubiquitin-proteasome system (UPS) and aberrant protein degradation. In vivo and in vitro studies have linked parkin, alpha-synuclein, and oxidative stress to a compromised UPS and PD pathogenesis suggesting novel therapeutic targets.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15629758     DOI: 10.1016/j.expneurol.2004.08.021

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  64 in total

Review 1.  Integration of clearance mechanisms: the proteasome and autophagy.

Authors:  Esther Wong; Ana Maria Cuervo
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-11-10       Impact factor: 10.005

2.  Neuroprotective upregulation of endogenous α-synuclein precedes ubiquitination in cultured dopaminergic neurons.

Authors:  R E J Musgrove; A E King; T C Dickson
Journal:  Neurotox Res       Date:  2010-07-09       Impact factor: 3.911

3.  Expression by midbrain dopamine neurons of Sema3A and 3F receptors is associated with chemorepulsion in vitro but a mild in vivo phenotype.

Authors:  Enrique R Torre; Claire-Anne Gutekunst; Robert E Gross
Journal:  Mol Cell Neurosci       Date:  2010-03-16       Impact factor: 4.314

Review 4.  Structure-function relationships of pre-fibrillar protein assemblies in Alzheimer's disease and related disorders.

Authors:  F Rahimi; A Shanmugam; G Bitan
Journal:  Curr Alzheimer Res       Date:  2008-06       Impact factor: 3.498

Review 5.  Genetics of iron regulation and the possible role of iron in Parkinson's disease.

Authors:  Shannon L Rhodes; Beate Ritz
Journal:  Neurobiol Dis       Date:  2008-07-11       Impact factor: 5.996

6.  Curcumin and its derivatives: their application in neuropharmacology and neuroscience in the 21st century.

Authors:  Wing-Hin Lee; Ching-Yee Loo; Mary Bebawy; Frederick Luk; Rebecca S Mason; Ramin Rohanizadeh
Journal:  Curr Neuropharmacol       Date:  2013-07       Impact factor: 7.363

Review 7.  The roles of the proteasome pathway in signal transduction and neurodegenerative diseases.

Authors:  Jiao-Jiao Chen; Fang Lin; Zheng-Hong Qin
Journal:  Neurosci Bull       Date:  2008-06       Impact factor: 5.203

Review 8.  Oxidative and inflammatory pathways in Parkinson's disease.

Authors:  Rebecca L Miller; Marilyn James-Kracke; Grace Y Sun; Albert Y Sun
Journal:  Neurochem Res       Date:  2008-03-25       Impact factor: 3.996

9.  Age-related memory deficits are associated with changes in protein degradation in brain regions critical for trace fear conditioning.

Authors:  Brooke N Dulka; Shane E Pullins; Patrick K Cullen; James R Moyer; Fred J Helmstetter
Journal:  Neurobiol Aging       Date:  2020-03-07       Impact factor: 4.673

Review 10.  Solvents and Parkinson disease: a systematic review of toxicological and epidemiological evidence.

Authors:  Edward A Lock; Jing Zhang; Harvey Checkoway
Journal:  Toxicol Appl Pharmacol       Date:  2012-12-07       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.